MOMA Therapeutics Appoints Semi Trotto as Chief People and Experience Officer
CAMBRIDGE, Mass., September 8, 2021 – MOMA Therapeutics, a biopharmaceutical company discovering the next generation of precision medicines by targeting molecular machines that underlie human disease, today announced that Semi…
Read More